Cancer Cells Go Incognito to Cause Therapy Relapse
4.7 (205) · $ 29.99 · In stock
Dormant cancer cells and dysfunctional immune cells living together in a tumor niche form a therapy-resistant reservoir.
Tumor News, Articles, The Scientist Magazine®
Clinical trial studies CAR T-cell therapy for relapsed/refractory acute myeloid leukemia
Cancers March-1 2024 - Browse Articles
Niki Spahich, PhD Author Profile, The Scientist Magazine®
Conventional and proposed chemotherapeutic strategies in cancer
New CAR T-Cell therapy extends remission in h
International BioDiscovery Federation
Cancers, Free Full-Text
Niki Spahich, PhD Author Profile, The Scientist Magazine®
Ann Tate's Instagram, Twitter & Facebook on IDCrawl
Ann Tate's Instagram, Twitter & Facebook on IDCrawl
Non-genetic cancer cell plasticity and therapy-induced stemness in tumour relapse: 'What does not kill me strengthens me
When dormancy fuels tumour relapse
